/PRNewswire/ FemiClear is proud to unveil BV & Yeast Infection Protection Vaginal Cream, designed to be used at known triggers to protect from possible.
– VOWSTTM is the first orally administered microbiome therapeutic FDA-approved for prevention of recurrence of C. difficile infection in adults following antibacterial treatment for recurrent CDI .
Seres Therapeutics, Inc. , a leading microbiome therapeutics company, today announced that Seres Therapeutics management, will participate in a question and answer format discussion at the Goldman. | June 9, 2023